Navigation Links
Everolimus slows disease progression in advanced papillary kidney cancer patients
Date:9/27/2013

in the Department of Oncology at the University of Vienna, Austria, commented: "Treatment strategies for metastatic renal cell cancer (RCC) have dramatically improved within the last few years. However, these achievements have been mostly restricted to patients with clear-cell (cc)-RCC. Patients with non-cc-RCC are usually underrepresented in clinical trials, thus the benefits of novel targeted agents remains unclear in this population. So far, attempts to investigate the impact of new drugs in the non-cc-RCC-population have resulted in inconsistent but mostly modest results. This is also due to the fact that studies included different types of non-cc-RCCs; however, these are tumours of different epithelial origin, with different genetic background and different clinical behaviour. RAPTOR is the first prospective study that investigated the impact of a targeted agent, everolimus, in patients with papillary RCC. In this study, Escudier et al demonstrated that everolimus provides a promising median average overall survival in this patient setting. A strength of this trial in contrast to other non-cc-RCC -studies is that only patients with papillary subtypes I and II were included, rather than all different types of non-cc-RCC."


'/>"/>

Contact: Kay Roche
kay@rochewriting.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Thwarting protein production slows cancer cells malignant march
2. Aging - Daily Sunscreen Use Slows the Visible Signs of Aging Skin
3. Skin Care – Sunscreen Slows Skin Aging
4. Skin Care – Daily Sunscreen Use Slows Skin Aging
5. Scientists discover how rapamycin slows cell growth
6. Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
7. Low-protein diet slows Alzheimers in mice
8. Newly approved oral medication slows rheumatoid arthritis joint damage
9. Active lifestyle boosts brain structure and slows Alzheimer’s disease
10. Mesothelioma drug slows disease progression in patients with an inactive NF2 gene
11. Mild HIV type slows development of AIDS and makes new preventive treatments possible
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... How would you describe your leadership ... all kinds of different leaders, each with their ... advantages and applications of different leadership styles, Ohio-based ... product this spring called The Leadership Report that ... personality type, leadership, and success. The Leadership Report ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Developers of ... of a new overlay plugin for Final Cut Pro X ... , “FCPX Overlay Chromatic gives users total control over 6k ... Austin, CEO of Pixel Film Studios. “FCPX Overlay Chromatic was ... easy to use interface.” , FCPX Overlay Chromatic Grunge 6K ...
(Date:2/28/2015)... 28, 2015 Memphis, TN: MedixSafe has ... for a new security reader named Guardian 2. ... is a new biometric scanner that significantly increases ... features, the new biometric scanner provides fast and ... , MedixSafe narcotics lockers with Vanguard ...
(Date:2/27/2015)... Hispanics develop alcoholic liver disease (ALD), a common ... earlier than Whites/Caucasians or African Americans, according to a ... previous research indicated that Hispanics tend to have more ... published online in the journal Alcoholism: Clinical and Experimental ... pinpoint racial and ethnic disparities in the ages at ...
(Date:2/27/2015)... Beverly Hills, CA (PRWEB) February 27, 2015 ... was in the air for those suffering from Sjögren’s ... had been discovered by researchers at the University of ... the next phase of research was to develop a ... to precisely detect the presence of new autoantibodies. Researchers ...
Breaking Medicine News(10 mins):Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2
... old-fashioned hard work, study says , , FRIDAY, Aug. ... exercise outcomes in people who have chronic obstructive ... , Creatine is a popular nutritional supplement used ... study included 100 COPD patients who received either ...
... of Diabetes and Digestive and Kidney Diseases (NIDDK) ... published several new resources to help people learn ... are among the most critical health problems in ... children and young adults. The publications address interstitial ...
... (Aug. 1, 2008) -- Quality of care varies greatly for ... of the country and category of health care facility, suggesting ... protocols, according to a new study that was published in ... Oncology (2008: Vol. 26, Issue 22). , The inconsistencies ...
... for completion of health risk assessment resulted in a 65% employee completion ... ... August 1, 2008 -- Employers are increasingly using incentives as the carrot ... issue brief from HealthFitness (OTC BB: HFIT) zeros in on the use ...
... consecutive year, Omega Institute will host an important conference at its ... disorders, to explore the latest research and development in treating and ... ... 1, 2008 -- For the second consecutive year, Omega Institute ...
... sleep apnea) is associated with an increased risk of ... Cohort, an 18-year observational study supported by the National ... Institutes of Health. Researchers found that adults (ages 30 ... the study were two to three times more likely ...
Cached Medicine News:Health News:Creatine Has Negligible Effect on COPD Exercise Rehab 2Health News:NIDDK publishes new resources about urologic and kidney disorders 2Health News:NIDDK publishes new resources about urologic and kidney disorders 3Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 3Health News:Omega to Hold Conference: Autism Through the Life Span II 2Health News:Omega to Hold Conference: Autism Through the Life Span II 3Health News:Sleep apnea linked to increased risk of death 2
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015  Pomerantz ... Vitae Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com ... whether Vitae and certain of its officers and/or directors ... Exchange Act of 1934.  On February ...
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... -- Report Details   Translational ... progress, and predicted revenues ,Where is the market for ... prospects for this market and related technologies? Visiongain,s brand ... to 2025, discussing data, opportunities and prospects. ... medicine : cell-based therapies that aim to restore function ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... 8, 2010 Substandard and counterfeit versions of thirteen ... Ghana by the Medicines Quality Monitoring surveillance program. Set ... in collaboration with the U.S. Pharmacopeial Convention (USP) and ... samples antimalarials across the public and private sectors. It ...
... WEST PALM BEACH, Fla., Nov. 8, 2010 ... Use and Health, teens abuse prescription medications more ... teens are under the misconception that these highly ... drugs. (Logo: http://photos.prnewswire.com/prnh/20100901/FL58348LOGO) ...
Cached Medicine Technology:Substandard and Counterfeit Antimalarial Drugs in Ghana Discovered by Cooperative Program of USP, Ghana Food and Drugs Board 2Substandard and Counterfeit Antimalarial Drugs in Ghana Discovered by Cooperative Program of USP, Ghana Food and Drugs Board 3Abuse Of Prescription Meds Among Teens Greater Than Most Illegal Drugs 2Abuse Of Prescription Meds Among Teens Greater Than Most Illegal Drugs 3
... is a unique microprocessor controlled shaking incubator ... either 96 or 384 well format. Speed, ... control panel and all are displayed on ... the clear protective cover. The Millennium 2000 ...
... the only four-color, automated benchtop flow cytometry ... cell sorting. Designed specifically to support a ... offers software instrument control, auto-sample loading, and ... productivity. FACSCalibur is fully modular so it ...
... Ultracompact high end desktop multilaser flow ... any kind of cell analysis and absolute ... forward and two different side scatter signals ... channels. The new CyFlow ML instrument can ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
Medicine Products: